Advertising
News
To the list of news

16 Apr 2026
Kinisis Ventures cites strong first-quarter progress across portfolio as startups accelerate commercial execution

Nicosia, Cyprus. Kinisis Ventures said its portfolio companies opened 2026 with stronger sales, product rollouts and market expansion across KVF I and KVF II. Several startups moved from development into commercial execution during the first quarter, according to the fund’s latest portfolio newsletter.


Threedium reports record opening quarter

Threedium posted its best opening quarter on record, surpassing $500,000 in new licence revenue for the first time. The company also built a pipeline exceeding $10 million and used NVIDIA GTC to announce its Agentic Product Brain, pointing to further growth in AI-driven commerce tools.

Autonomics expands live hospitality deployments in Athens

Autonomics moved further into live hospitality deployments, with its technology now operating at the Four Seasons Astir Palace and Astir Marina in Athens. The company also received a BOOST grant from the Cyprus Research and Innovation Foundation (RIF), alongside its expansion in high-end hospitality environments.

Embio Diagnostics widens international reach

Embio Diagnostics expanded operations to more than 15 countries. The company was selected to present at SusHi Tech Tokyo 2026 at Google for Startups while continuing the rollout of its Prometheus and Athena devices.

IREROBOT advances internationalisation and US market entry

IREROBOT joined Google for Startups and secured $100,000 in cloud credits. The company submitted its Bluetooth XR Kit to the Unity Store and continued advancing its US market entry through the YBI Engine Tech Incubator.

Additional portfolio updates

Promed moved into scale-up mode and added a cosmetics client. Heroes Made expanded its US distribution footprint across five states.


Which of these portfolio companies’ next milestones will you be watching most closely?

Показать комментарии
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments